Meningioma and Cerebral Spindle Cell Sarcoma as Two Different Metachronous Tumor Entities Secondary to Medulloblastoma Treatment in Childhood: Case Report and Review of the Literature

Abstract

The authors report on a 21-year-old clinically asymptomatic female patient, who was admitted with two supratentorial intradural lesions in her follow-up magnetic resonance imaging 17 years after treatment of a posterior fossa medulloblastoma. Sequential surgical removal was performed. The left parietal tumor with dural involvement was diagnosed as a transitional meningioma WHO (World Health Organization) grade 1. The right temporal lesion, which had also close relationship to the dura, was diagnosed as a spindle cell sarcoma. We therefore report a metachronous tumor development of a benign and a malignant intradural sarcomatous tumor as secondary neoplasms following childhood medulloblastoma treatment.

Keywords

spindle cell sarcoma - meningioma - medulloblastoma

Publikationsverlauf

Eingereicht: 06. Januar 2025

Angenommen: 20. Mai 2025

Accepted Manuscript online:
22. Mai 2025

Artikel online veröffentlicht:
18. September 2025

• References

• 1 Choi JY. Medulloblastoma: current perspectives and recent advances. Brain Tumor Res Treat 2023; 11 (01) 28-38
• 2 Millard NE, De Braganca KC. Medulloblastoma. J Child Neurol 2016; 31 (12) 1341-1353
• 3 Mynarek M, Obrecht D, Sill M. et al. Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts. Acta Neuropathol 2023; 145 (01) 97-112
• 4 Gerlach R, Kieslich M, van de Nes J, Galow W, Seifert V. Supratentorial leptomeningeal metastasis of a medulloblastoma without cerebellar tumor recurrence. Acta Neurochir (Wien) 2002; 144 (02) 201-204 , discussion 204
• 5 Sure U, Bertalanffy H, Isenmann S. et al. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients. Acta Neurochir (Wien) 1995; 136 (3-4): 117-126
• 6 Dietzsch S, Placzek F, Pietschmann K. et al. Evaluation of prognostic factors and role of participation in a randomized trial or a prospective registry in pediatric and adolescent nonmetastatic medulloblastoma - a report from the HIT 2000 trial. Adv Radiat Oncol 2020; 5 (06) 1158-1169
• 7 Goldstein AM, Yuen J, Tucker MA. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 1997; 8 (06) 865-871
• 8 Friedrich C, von Bueren AO, von Hoff K. et al. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer 2013; 49 (04) 893-903
• 9 Packer RJ, Siegel KR, Sutton LN. et al. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report. Ann Neurol 1988; 24 (04) 503-508
• 10 Packer RJ, Gajjar A, Vezina G. et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006; 24 (25) 4202-4208
• 11 Gajjar A, Chintagumpala M, Ashley D. et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7 (10) 813-820
• 12 Jakacki RI, Burger PC, Zhou T. et al. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. J Clin Oncol 2012; 30 (21) 2648-2653
• 13 Grill J, Sainte-Rose C, Jouvet A. et al; French Society of Paediatric Oncology. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 2005; 6 (08) 573-580
• 14 Bowers DC, Gargan L, Weprin BE. et al. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma. J Neurosurg 2007; 107 (1, Suppl): 5-10
• 15 Hope AJ, Mansur DB, Tu PH, Simpson JR. Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma. Childs Nerv Syst 2006; 22 (09) 1201-1207
• 16 Anderson JR, Treip CS. Radiation-induced intracranial neoplasms. A report of three possible cases. Cancer 1984; 53 (03) 426-429
• 17 Ron E, Modan B, Boice Jr JD. et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319 (16) 1033-1039
• 18 Bachman DS, Ostrow PT. Fatal long-term sequela following radiation “cure” for ependymoma. Ann Neurol 1978; 4 (04) 319-321
• 19 Kaschten B, Flandroy P, Reznik M, Hainaut H, Stevenaert A. Radiation-induced gliosarcoma. Case report and review of the literature. J Neurosurg 1995; 83 (01) 154-162
• 20 Chang SM, Barker II FG, Larson DA, Bollen AW, Prados MD. Sarcomas subsequent to cranial irradiation. Neurosurgery 1995; 36 (04) 685-690
• 21 Benjamin C, Shah JK, Kondziolka D. Radiation-induced meningiomas. Handb Clin Neurol 2020; 169: 273-284
• 22 Yamanaka R, Hayano A, Kanayama T. Radiation-induced meningiomas: an exhaustive review of the literature. World Neurosurg 2017; 97: 635-644.e8
• 23 Amendola BE, Amendola MA, McClatchey KD, Miller Jr CH. Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol 1989; 12 (05) 411-415
• 24 Kumar PP, Good RR, Skultety FM, Leibrock LG, Severson GS. Radiation-induced neoplasms of the brain. Cancer 1987; 59 (07) 1274-1282
• 25 Tountas AA, Fornasier VL, Harwood AR, Leung PM. Postirradiation sarcoma of bone: a perspective. Cancer 1979; 43 (01) 182-187
• 26 Lee CY, Chen YW, Lee YY. et al. Irradiation-induced secondary tumors following pediatric central nervous system tumors: experiences of a single institute in Taiwan (1975-2013). Int J Radiat Oncol Biol Phys 2018; 101 (05) 1243-1252
• 27 Dudvarski Z, Arsovic N, Sopta J, Gacic-Manojlovic E, Radivojevic N, Jakovljevic S. Secondary Ewing's sarcoma of the temporo-occipital region developed 12-years after medulloblastoma treatment. Braz J Otorhinolaryngol 2022; 88 (Suppl 4, Suppl 4): S226-S229
• 28 Nejo T, Takayanagi S, Tanaka S. et al. Primary intracranial spindle cell sarcoma, DICER1-mutant, with MDM2 amplification diagnosed on the basis of extensive molecular profiling. Clin Med Insights Case Rep 2022; 15: 11 795476221131189
• 29 Lafay-Cousin L, Lindzon G, Taylor MD. et al. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children. J Neurosurg Pediatr 2016; 17 (03) 298-302